Hibergene
Rapid molecular tests for infectious disease
Total raised
€6.2M
€6,240,000
Funding rounds
1
Investors
0
distinct backers
Active since
2017-02
latest 2017-02
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood19
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Series B | €6.2M | — | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech